Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia
Clinical trial NCT00077714 · COMPLETED
Trial details
- NCT number
- NCT00077714
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.